Showing 16,921 - 16,940 results of 133,536 for search '(( a d decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.15s Refine Results
  1. 16921

    Comparison of Cyclic and Linear PEG Conjugates by Grace E. Kunkel (18630873)

    Published 2024
    “…Here, we report the first bioconjugation of a cyclic polymer, poly­(ethylene glycol) (PEG), to a model protein, T4 lysozyme, containing a single engineered cysteine residue (V131C). …”
  2. 16922

    Comparison of Cyclic and Linear PEG Conjugates by Grace E. Kunkel (18630873)

    Published 2024
    “…Here, we report the first bioconjugation of a cyclic polymer, poly­(ethylene glycol) (PEG), to a model protein, T4 lysozyme, containing a single engineered cysteine residue (V131C). …”
  3. 16923

    <i>Rpl5</i> mutant ES cells exhibit a p53-independent G2 cell cycle arrest. by Sharon A. Singh (524066)

    Published 2014
    “…In contrast, the cell cycle profile of the <i>Rpl5</i> mutant ES cells exhibited a three-fold increase in the G2 phase with a concomitant decrease in the G1 and S phases, consistent with a delayed G2 phase transition (A, C) (three independent pooled experiments). …”
  4. 16924
  5. 16925
  6. 16926
  7. 16927
  8. 16928

    Evaluation of novel 3-D invasion assay. by Nikki A. Evensen (495977)

    Published 2013
    “…<p>A & B) Comparison of the novel 3-D invasion assay and 3-D cell scattering assay: The effect of control IgG (Rabbit, 10 μg/ml), tissue inhibitor of metalloproteinase-2 (TIMP-2) (10 nM), or anti-MT1-MMP-hemopexin domain antibody (Anti-PEX Ab) (10 μg/ml) on MT1-GFP-induced LNCaP cell invasion was evaluated via the 3-D invasion assay (A) and 3-D cell scattering assay (B). …”
  9. 16929
  10. 16930
  11. 16931

    Photochemistry and Photophysics of Charge-Transfer Excited States in Emissive <i>d</i><sup>10</sup>/<i>d</i><sup>0</sup> Heterobimetallic Titanocene Tweezer Complexes by Henry C. London (11408928)

    Published 2022
    “…Transition-metal complexes that undergo ligand-to-metal charge transfer (LMCT) to <i>d</i><sup>0</sup> metals are of interest as possible photocatalysts due to the lack of deactivating dd states. …”
  12. 16932

    Individual data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  13. 16933

    Household data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  14. 16934

    Persons with epilepsy data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  15. 16935

    Ivermectin coverage in 2019 and 2021. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  16. 16936

    Individual data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  17. 16937

    Household data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  18. 16938

    Persons with epilepsy data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  19. 16939
  20. 16940